IMDX
Insight Molecular Diagnostics Inc. · Healthcare
Broadwood Partners, L.P. bought $653K of Insight Molecular Diagnostics Inc.
10% owner
Bought$652,876
$3.57Price
182,861Shares
+1%Stake
What IMDX did for a copier
- $1,000 copied at Tue, Apr 21 open, $4.30
- $1,402
- S&P 500, same days
- +6.2%
Measured over 30 trading days, to the Jun 3 close.
Broadwood Partners, L.P.'s record
28 other buys with 3 months of prices since 2018: on average −1.9% against the S&P 500, and 11 of 28 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Apr 16. Filed Mon, Apr 20, 7:24 PM ET, after the close. Returns use the Apr 21 open and the Jun 3 close. Not investment advice.